IBUPROFEN-FAMOTIDIN 800-26.6 MG
For 30 tablets
Pharmacies pay
$21.41 filed
30 × $0.71383 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$84.24 filed
30 × $2.80793 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.9× estimated
Medicare paid 3.9× what pharmacies pay.
Part D averages every strength and form sold under “Ibuprofen-Famotidine” / “Ibuprofen/FAmotidine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$29.62 estimated
$21.41 + $3.21 (15%) + $5.00 fee per fill = $29.62
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
IBUPROFEN-FAMOTIDIN 800-26.6 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ibuprofen and famotidine.
FDA gives its dosage form as “tablet” and “tablet, film coated” and its route as oral.
FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Camber Pharmaceuticals, Inc., Par Health USA, LLC and Ascend Laboratories, LLC.
FDA lists it under 2 Established Pharmacologic Classes: Histamine-2 Receptor Antagonist and Nonsteroidal Anti-inflammatory Drug.
The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $21.41 for 30 tablets (30 × $0.71383 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 4 NDCs
- 31722-0315-90 · Camber Pharmaceuticals, Inc. · $0.71383 per EA · eff. 2026-09-23 filed
- 49884-0366-09 · Par Health USA, LLC · $0.71383 per EA · eff. 2026-09-23 filed
- 67877-0626-90 · Ascend Laboratories, LLC · $0.71383 per EA · eff. 2026-09-23 filed
- 72578-0214-16 · Viona Pharmaceuticals Inc · $0.71383 per EA · eff. 2026-09-23 filed
Compared with its class
The middle of its 4 NDCs’ NADAC prices is $0.71383 per EA filed.
Of the 23 other products in FDA’s Histamine-2 Receptor Antagonist class priced per EA, 3 have a higher middle NADAC price and 20 a lower one. The one in the middle is HEARTBURN RELIEF 20 MG TABLET, at $0.13819 per EA filed (eff. 2026-09-23).
Of the 154 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per EA, 34 have a higher middle NADAC price and 120 a lower one. The one in the middle is INDOMETHACIN 25 MG CAPSULE, at $0.09341 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $84.24 for 30 tablets, at an average of $2.80793 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ibuprofen-Famotidine” and “Ibuprofen/FAmotidine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 9,913 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for IBUPROFEN-FAMOTIDIN 800-26.6 MG labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Ibuprofen-Famotidine / Ibuprofen/FAmotidine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic classes
Related in the same class
- IBUPROFEN 400 MG TABLET
- CELECOXIB 100 MG CAPSULE
- NABUMETONE 500 MG TABLET
- DICLOFENAC POT 25 MG TABLET
- INDOMETHACIN 25 MG CAPSULE